Publication related to RSI or an RSI staff member
Assessment of Patterns of Potentially Unsafe Use of Zolpidem.
Authors
- Moore, Thomas J, Moore TJ, Institute for Safe Medication Practices, Alexandria, Virginia.; Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, Washington, DC.
- Mattison, Donald R, Mattison DR, Risk Sciences International, Ottawa, Ontario, Canada.
YEAR OF PUBLICATION: 2018
SOURCE: JAMA Intern Med. 2018 Sep 1;178(9):1275-1277. doi: 10.1001/jamainternmed.2018.3031.
JOURNAL TITLE ABBREVIATION: JAMA Intern Med
JOURNAL TITLE: JAMA internal medicine
ISSN: 2168-6114 (Electronic) 2168-6106 (Print) 2168-6106 (Linking)
VOLUME: 178
ISSUE: 9
PAGES: 1275-1277
PLACE OF PUBLICATION: United States
ABSTRACT:
This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
LANGUAGE: eng
DATE OF PUBLICATION: 2018 Sep 1
DATE COMPLETED: 20190912
DATE REVISED: 20200225
MESH DATE: 2019/09/13 06:00
EDAT: 2018/07/18 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1001/jamainternmed.2018.3031 [doi]
OWNER: NLM
Related RSI Experts
Chief Medical Officer, Senior Vice-President
Dr. Donald Mattison joined Risk Sciences International (RSI) in 2012 as Senior Vice-President and Chief Medical Officer, bringing with him a distinguished career spanning public health, clinical medicine, toxicology, and academic leadership. His appointment significantly strengthened RSI’s capacity to deliver...